8 February, 2018
Baker McKenzie is pleased to announce the release of our 2018 Healthcare Sector Forecast ("Healthcare Forecast") on 8 January 2018. The Healthcare Forecast is the latest in a series of industry-focused white papers following the launch of our 2018 Global Transactions Forecast.
The Healthcare Forecast predicts a rebound in healthcare M&A deal activity in 2018, following a slowdown in 2017 as a result of uncertainty over Brexit, the US presidential election, and the US tax reform signed on 22 December 2017. Activities that are predicted to accelerate include pharmaceutical companies shedding non-core assets while pursuing smaller bolt-on acquisitions, as well as licensing deals to gain access to the next wave of game-changing treatments in areas such as immuno-oncology, cardiovascular disease, and diabetes.
The Healthcare Forecast also makes predictions of healthcare M&A and IPOs across various jurisdictions in 2018.
A copy of the Healthcare Forecast may be downloaded here.
For further information, please contact:
Andy Leck, Principal, Baker & McKenzie.Wong & Leow
andy.leck@bakermckenzie.com
